Nervonik

Designed For Motion

Los Angeles, United States · $52.5M raised

Employees
1–10
Business Model
B2B
Total Funding
$52.5M
Last Round
$52.5M SAFEApr 2026
Rounds
3

About

Nervonik is developing next-generation peripheral nerve stimulation (PNS) technology featuring a novel, patented trifecta system that eliminates technical barriers to biosensing in high-motion applications. The company's miniaturized devices address limitations of existing PNS devices by improving lead placement, programming flexibility, energy efficiency, and long-term efficacy. Nervonik's technology is currently under development and has not yet received FDA clearance or approval.

Summary

Nervonik is a Healthcare company based in Los Angeles, United States. It has raised $52.5M in total across 3 rounds, most recently a $52.5M SAFE round in Apr 2026. Investors include ShangBay Capital, Camford Capital and Joyance Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BApr 2026
$52.5M

Sign up to see all 3 rounds

SAFE through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nervonik on Indexed.vc
<a href="https://indexed.vc/companies/nervonik"><img src="https://indexed.vc/api/badge/company/nervonik" alt="Nervonik on Indexed.vc" width="260" height="76" /></a>